- Home
- CMMB vs CKX Comparison
CMMB vs CKX Comparison
Compare CMMB & CKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- CKX
- Stock Information
- Founded
- CMMB 2004
- CKX 1930
- Country
- CMMB Israel
- CKX United States
- Employees
- CMMB N/A
- CKX N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- CKX Oil & Gas Production
- Sector
- CMMB Health Care
- CKX Energy
- Exchange
- CMMB Nasdaq
- CKX Nasdaq
- Market Cap
- CMMB 27.0M
- CKX 25.4M
- IPO Year
- CMMB N/A
- CKX 1998
- Fundamental
- Price
- CMMB $1.60
- CKX $12.51
- Analyst Decision
- CMMB Strong Buy
- CKX
- Analyst Count
- CMMB 3
- CKX 0
- Target Price
- CMMB $7.33
- CKX N/A
- AVG Volume (30 Days)
- CMMB 119.1K
- CKX 1.2K
- Earning Date
- CMMB 11-14-2024
- CKX 01-01-0001
- Dividend Yield
- CMMB N/A
- CKX N/A
- EPS Growth
- CMMB N/A
- CKX N/A
- EPS
- CMMB N/A
- CKX 0.22
- Revenue
- CMMB N/A
- CKX $2,030,981.00
- Revenue This Year
- CMMB N/A
- CKX N/A
- Revenue Next Year
- CMMB N/A
- CKX N/A
- P/E Ratio
- CMMB N/A
- CKX $55.64
- Revenue Growth
- CMMB N/A
- CKX 88.35
- 52 Week Low
- CMMB $0.42
- CKX $12.41
- 52 Week High
- CMMB $2.55
- CKX $14.44
- Technical
- Relative Strength Index (RSI)
- CMMB 52.53
- CKX 34.77
- Support Level
- CMMB $1.54
- CKX $12.41
- Resistance Level
- CMMB $1.73
- CKX $12.93
- Average True Range (ATR)
- CMMB 0.16
- CKX 0.17
- MACD
- CMMB 0.01
- CKX -0.02
- Stochastic Oscillator
- CMMB 45.45
- CKX 10.64
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About CKX CKX Lands Inc.
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership in the form of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields.